Alkermes (ALKS) Tops Q1 EPS by 11c

Go back to Alkermes (ALKS) Tops Q1 EPS by 11c

Alkermes plc Reports First Quarter 2022 Financial Results

April 27, 2022 7:00 AM EDT

  First Quarter Revenues of $278.5 Million Reflect Strong Performance of LYBALVI®, ARISTADA® and VIVITROL®

  GAAP Loss per Share of $0.22 and Basic and Diluted Non-GAAP Earnings per Share of $0.12   

  Financial Expectations for 2022 Reiterated

DUBLIN, April 27, 2022 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) today reported financial results... More